MO
Therapeutic Areas
Bionano Genomics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Stratys™ System | Optical Genome Mapping for clinical research & cytogenomics | Commercial |
| Saphyr® System | Optical Genome Mapping for research use | Commercial |
| VIA Software | Integrated analysis of OGM, NGS, and microarray data | Commercial |
| Ionic® Purification System | Isolation of UHMW DNA/RNA | Commercial |
| OGM for Hematological Malignancies | Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) and other blood cancers | Clinical Research |
| OGM for Genetic Disease | Neurodevelopmental delay, rare disease, reproductive health | Clinical Research |
| OGM for Cell Bioprocessing QC | Genomic integrity of cell therapy and producer cell lines | Commercial |
Leadership Team at Bionano Genomics
EH
Erik Holmlin, PhD
President and Chief Executive Officer
AC
Alka Chaubey, PhD, FACMG
Chief Medical Officer
JD
Jonathan Dixon
General Counsel
DP
Donna Polizio
Global Head of Market Access
MA
Mark Adamchak, CPA
Vice President, Accounting
CK
Cory Kreeck
Global Head of People Operations